41 Mins
Source:
الوطن
Advanced Medicine Outlook
The “Oman Nucleus” project to produce radiopharmaceuticals, backed by investments of OMR 6.5 million, marks a step toward advancing modern medicine and localizing medical industries. It was announced by the Oman Investment Authority in partnership with Saudi company Al Maha Isotopes and in cooperation with the Ministries of Health and Finance. The project is expected to help ensure the supply of radiopharmaceuticals used to diagnose and treat cancer, heart and neurological diseases, and to strengthen the reliability of supply. It will also establish a laboratory to calibrate radiation-measuring devices in accordance with international standards. In addition, the project aims to transfer technology and expertise, train Omani professionals, and create economic opportunities in areas including research and development and supporting industries—advancing the objectives of Oman Vision 2040.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)